广发纳斯达克生物科技人民币(001092)

动态评分: 5.23分

投资组合

报告日期 名称 比例
2021-12-31 Repare Therapeutics Inc 0.07%
2021-12-31 uniQure NV 0.07%
2021-12-31 Rubius Therapeutics Inc 0.07%
2021-12-31 Prometheus Biosciences Inc 0.07%
2021-12-31 C4 Therapeutics Inc 0.07%
2021-12-31 Arcturus Therapeutics Holdings Inc 0.07%
2021-12-31 MacroGenics Inc 0.07%
2021-12-31 Gossamer Bio Inc 0.07%
2021-12-31 IDEAYA生物科学 0.07%
2021-12-31 Immunovant Inc 0.07%
2021-12-31 Inovio制药 0.07%
2021-12-31 Stoke Therapeutics Inc 0.07%
2021-12-31 AlloVir Inc 0.07%
2021-12-31 远藤制药 0.07%
2021-12-31 MeiraGTx Holdings plc 0.07%
2021-12-31 Anavex Life Sciences Corp 0.06%
2021-12-31 Bicycle Therapeutics Ltd ADR 0.06%
2021-12-31 Personalis Inc 0.06%
2021-12-31 Theravance Biopharma Inc 0.06%
2021-12-31 Sutro Biopharma Inc 0.06%

投资模拟

公告&资料